πŸ‡ΊπŸ‡Έ FDA
Patent

US 8785492

Treatment of circadian rhythm disorders

granted A61KA61K31/00A61K31/05

Quick answer

US patent 8785492 (Treatment of circadian rhythm disorders) held by VANDA PHARMACEUTICALS INC. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/00, A61K31/05, A61K31/15, A61K31/277